There is a widespread notion that inhibition of AChE could prevent the metabolic processes of acetylcholine (ACh), a neurotransmitter that supports cognitive function in the cerebral cortex and hippocampus, which in turn enhances the ACh levels and delays cognitive decline. The gene discussed is ACHE; the disease is Mental deterioration.